
Shahzad Malik
QuietNamed in filings at Advent Life SciencesOn the current fund
- Board seats filed
- 9

Named in filings at Advent Life SciencesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Moximed | Medical devices | August 2024 | NEA |
| Iterum Therapeutics Bermuda | Biotech & pharma | January 2020 | Frazier Life Sciences, Sofinnova Venture Partners, Tapestry VC |
| Iterum Therapeutics plc | Biotech & pharma | May 2017 | Frazier Life Sciences, Tapestry VC |
| Axonics Modulation Technologies | Medical devices | December 2015 | None on file |
| Nalu Medical | Medical devices | June 2015 | None on file |
| AGENUS | Biotech & pharma | February 2015 | None on file |
| Versartis | Biotech & pharma | February 2014 | Medicxi, Samsara Biocapital |
| IDUN PHARMACEUTICALS | Biotech & pharma | February 2014 | MPM BioVentures |
| Acutus Medical | Medical devices | June 2013 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Shahzad Malik on the board, based on 9 filed seats with a verified or cited source.